{"id":20616,"date":"2021-02-18T05:00:00","date_gmt":"2021-02-17T22:00:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2021021805000020616"},"modified":"2021-02-18T21:38:23","modified_gmt":"2021-02-18T13:38:23","slug":"boston-immune-technologies-and-therapeutics%e5%92%8c%e7%99%be%e6%b5%8e%e7%a5%9e%e5%b7%9e%e5%b0%b1%e5%bc%80%e5%8f%91%e6%96%b0%e5%9e%8btnfr2%e6%8b%ae%e6%8a%97%e5%89%82%e8%be%be%e6%88%90%e7%8b%ac","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2021021805000020616","title":{"rendered":"Boston Immune Technologies and Therapeutics\u548c\u767e\u6d4e\u795e\u5dde\u5c31\u5f00\u53d1\u65b0\u578bTNFR2\u62ee\u6297\u5242\u8fbe\u6210\u72ec\u5bb6\u9009\u62e9\u548c\u6388\u6743\u534f\u8bae"},"content":{"rendered":"

\u53cc\u65b9\u5728\u4e9a\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u8fbe\u6210\u72ec\u5bb6\u6388\u6743\uff0c\u5df2\u8ba1\u5212\u5f00\u5c55\u4e0e\u767e\u6d4e\u795e\u5dde\u6297PD-1\u6297\u4f53\u767e\u6cfd\u5b89\u00ae\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\uff09\u8054\u5408\u7684\u7814\u7a76<\/span><\/p>\n

\u7f8e\u56fd\u9ebb\u7701\u6ce2\u58eb\u987f\u3001\u5251\u6865\u548c\u4e2d\u56fd\u5317\u4eac2021\u5e742\u670818\u65e5 \/\u7f8e\u901a\u793e\/ — Boston Immune Technologies and Therapeutics, Inc.\uff08\u4ee5\u4e0b\u7b80\u79f0\u201cBITT\u201d\uff09\u662f\u4e00\u5bb6\u5728\u764c\u75c7\u548c\u5176\u4ed6\u75be\u75c5\u9886\u57df\u4e13\u6ce8\u5f00\u53d1\u65b0\u578b\u62ee\u6297\u5242\u6297\u4f53\u7684\u79c1\u6709\u516c\u53f8\uff0c\u516c\u53f8\u4eca\u5929\u548c\u767e\u6d4e\u795e\u5dde\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aBGNE\uff1b\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a06160\uff09\u5ba3\u5e03\uff0c\u53cc\u65b9\u5df2\u8fbe\u6210\u4e00\u9879\u9009\u62e9\u548c\u6388\u6743\u534f\u8bae\uff0c\u76ee\u7684\u4e3a\u5f00\u53d1\u548c\u5546\u4e1a\u5316BITT\u521b\u65b0\u80bf\u7624\u574f\u6b7b\u56e0\u5b50\uff08TNF\uff09\u53d7\u4f532\u578b\uff08TNFR2\uff09\u62ee\u6297\u5242\u6297\u4f53\u3002\u767e\u6d4e\u795e\u5dde\u5df2\u7ecf\u83b7\u5f97BITT\u4e13\u5229\u4fdd\u62a4\u7684TNFR2\u62ee\u6297\u5242\u6297\u4f53\u5728\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u7684\u72ec\u5bb6\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u5316\u6388\u6743\u9009\u62e9\u6743\uff0c\u5305\u62ec\u4e9a\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u3002\u53cc\u65b9\u8ba1\u5212\u80fd\u542f\u52a8\u591a\u98791\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u7528\u4e8e\u8bc4\u4f30BITT\u7684\u5148\u8fdbTNFR2\u62ee\u6297\u5242\u6297\u4f53BITR2101\uff0c\u5305\u62ec\u5176\u8054\u5408\u767e\u6d4e\u795e\u5dde\u6297PD-1\u6297\u4f53\u767e\u6cfd\u5b89®<\/sup>\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\uff09\u7684\u7ec4\u5408\u7528\u836f\u7814\u7a76\u3002<\/p>\n

BITT\u8054\u5408\u521b\u59cb\u4eba\u517c\u9996\u5e2d\u6267\u884c\u5b98Russell LaMontagne\u8868\u793a\uff1a\u201c\u4f5c\u4e3a\u4e00\u5bb6\u5168\u7403\u6027\u516c\u53f8\uff0c\u767e\u6d4e\u795e\u5dde\u5728\u652f\u6301\u751f\u7269\u79d1\u6280\u521b\u65b0\u65b9\u9762\u7ecf\u9a8c\u4e30\u5bcc\u3001\u58f0\u8a89\u5353\u8d8a\uff0c\u4e5f\u662f\u5e2e\u52a9\u5f00\u53d1\u6211\u4eec\u5148\u8fdb\u7684\u5728\u7814TNFR2\u6297\u4f53BITR2101\u7684\u7406\u60f3\u5408\u4f5c\u4f19\u4f34\u3002\u80fd\u4e0e\u767e\u6d4e\u795e\u5dde\u8fbe\u6210\u8be5\u9879\u5408\u4f5c\uff0c\u5728\u80af\u5b9aBITT\u6297\u4f53\u5f00\u53d1\u5e73\u53f0\u6280\u672f\u7684\u540c\u65f6\uff0c\u4e5f\u4e3aBITR2101\u8bc1\u660e\u5176\u6f5c\u529b\u63d0\u4f9b\u4e86\u4e00\u4e2a\u673a\u4f1a\uff0c\u65e0\u8bba\u662f\u4f5c\u4e3a\u5355\u836f\uff0c\u8fd8\u662f\u4e0e\u7c7b\u4f3c\u767e\u6cfd\u5b89®<\/sup>\u7684\u68c0\u67e5\u70b9\u6291\u5236\u5242\u8054\u5408\u3002\u201d<\/p>\n

TNFR2\u4e3aTNF\u53d7\u4f53\u8d85\u5bb6\u65cf\u6210\u5458\uff0c\u5728\u591a\u7c7b\u80bf\u7624\u4e2d\u7684\u9009\u62e9\u6027\u8868\u8fbe\u4e3a\u8868\u9762\u764c\u57fa\u56e0\uff0c\u5177\u6709\u4fc3\u8fdb\u80bf\u7624\u7ec6\u80de\u589e\u6b96\u7684\u529f\u80fd\u3002TNFR2\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\u4e5f\u4f1a\u8868\u8fbe\u5728\u6291\u5236\u6027\u514d\u75ab\u7ec6\u80de\u4e2d\uff0c\u5305\u62ec\u8c03\u8282\u6027T\u7ec6\u80de\uff08Tregs\uff09\u548c\u9ad3\u6e90\u6291\u5236\u6027\u7ec6\u80de\uff0c\u540c\u65f6\u4e5f\u662f\u514d\u75ab\u9003\u9038\u3001\u80bf\u7624\u751f\u957f\u4ee5\u53ca\u68c0\u67e5\u70b9\u963b\u65ad\u62b5\u6297\u6027\u7684\u6f5c\u5728\u9a71\u52a8\u529b\u3002<\/p>\n

\u767e\u6d4e\u795e\u5dde\u9ad8\u7ea7\u526f\u603b\u88c1\u517c\u5916\u90e8\u521b\u65b0\u8d1f\u8d23\u4eba\u7f57\u4fa3\u677e\u535a\u58eb\u8bc4\u8bba\u9053\uff1a\u201cTNFR2\u662f\u4e00\u79cd\u5341\u5206\u6709\u610f\u601d\u7684\u9776\u70b9\uff0c\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\uff0c\u4f1a\u5728\u6291\u5236\u6027\u7ec6\u80de\u4e0a\u9ad8\u8868\u8fbe\u3002\u540c\u65f6\uff0c\u5b66\u754c\u4e5f\u6b63\u9010\u6e10\u8fbe\u6210\u5171\u8bc6\u2014\u2014TNFR2\u9776\u70b9\u4e5f\u8bb8\u4f1a\u6210\u4e3a\u6cbb\u7597\u764c\u75c7\u7684\u4e00\u6761\u65b0\u9896\u4e14\u6709\u6548\u7684\u9014\u5f84\u3002BITT\u5df2\u521b\u9020\u51fa\u9ad8\u5ea6\u80bf\u7624\u7279\u5b9a\u6027\u7684\u6297\u4f53\uff0c\u5177\u6709\u72ec\u7279\u3001\u65b0\u9896\u7684\u7ed3\u5408\u5f62\u6001\u3002\u6211\u4eec\u671f\u5f85\u4e0eBITT\u5408\u4f5c\uff0c\u770b\u5230BITR2101\u4f5c\u4e3a\u5355\u836f\u4ee5\u53ca\u4e0e\u767e\u6cfd\u5b89®<\/sup>\u8054\u5408\u7684\u4e34\u5e8a\u6570\u636e\u3002\u201d<\/p>\n

\u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0cBITT\u5c06\u83b7\u5f97\u5171\u8ba11660\u4e07\u7f8e\u5143\u7684\u9884\u4ed8\u6b3e\u4ee5\u53ca\u8fd1\u671f\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff0c\u5176\u4e2d\u5305\u62ec\u767e\u6d4e\u795e\u5dde\u5728\u6982\u5ff5\u9a8c\u8bc1\u7814\u7a76\u540e\u884c\u4f7f\u9009\u62e9\u6743\u3002\u6b64\u5916\uff0c\u5728\u767e\u6d4e\u795e\u5dde\u884c\u4f7f\u9009\u62e9\u6743\u540e\uff0cBITT\u6709\u8d44\u683c\u83b7\u5f97\u81f3\u591a\u4e3a1.05\u4ebf\u7f8e\u5143\u7684\u5f00\u53d1\u3001\u6ce8\u518c\u53ca\u9500\u552e\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff0c\u53e6\u52a0\u5728\u6388\u6743\u5730\u533a\u7684\u5206\u7ea7\u4ea7\u54c1\u9500\u552e\u7279\u8bb8\u4f7f\u7528\u8d39\u3002\u8fde\u540c\u8be5\u9879\u72ec\u5bb6\u9009\u62e9\u548c\u6388\u6743\u534f\u8bae\uff0c\u767e\u6d4e\u795e\u5dde\u540c\u65f6\u53c2\u4e0e\u4e86BITT\u7684A\u8f6e\u4f18\u5148\u80a1\u878d\u8d44\uff0c\u4e3a\u5176\u6295\u8d44400\u4e07\u7f8e\u5143\u3002<\/p>\n

\u5173\u4e8e<\/b>Boston Immune Technologies and Therapeutics<\/b><\/p>\n

Boston Immune Technologies and Therapeutics\uff08BITT\uff09\u662f\u4e00\u5bb6\u4f4d\u4e8e\u7f8e\u56fd\u6ce2\u58eb\u987f\u7684\u516c\u53f8\uff0c\u5728\u80bf\u7624\u3001\u708e\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u6027\u548c\u611f\u67d3\u6027\u75be\u75c5\u9886\u57df\u4e2d\uff0c\u4e13\u6ce8\u5f00\u53d1TNF\u8d85\u5bb6\u65cf\u53d7\u4f53\u7684\u65b0\u578b\u62ee\u6297\u5242\u6297\u4f53\u3002BITR2101\u4e3a\u516c\u53f8\u6700\u4e3a\u5148\u8fdb\u7684\u5019\u9009\u836f\u7269\uff0c\u662f\u4e00\u6b3e\u4ee5\u80bf\u7624\u574f\u6b7b\u56e0\u5b50\u53d7\u4f532\u578b\uff08TNFR2\uff09\u4e3a\u9776\u70b9\u7684\u5355\u514b\u9686\u6297\u4f53\uff0cBITT\u6b63\u5728\u8ba1\u5212\u542f\u52a8BITR2101\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002\u540c\u65f6\uff0cBITT\u6b63\u5728\u5f00\u53d1\u5176\u4ed6\u591a\u9879TNF\u8d85\u5bb6\u65cf\u6297\u4f53\uff0c\u5305\u62ec\u5728\u9a8c\u8bc1\u4e2d\u5f00\u53d1CD40\u62ee\u6297\u5242\u3001\u5728\u80bf\u7624\u5b66\u4e2d\u5f00\u53d1CD30\u62ee\u6297\u5242\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u516c\u53f8\u5b98\u7f51www.bostonimmunetech.com<\/a><\/u>\u3002<\/p>\n

\u5173\u4e8e\u767e\u6d4e\u795e\u5dde<\/b><\/p>\n

\u767e\u6d4e\u795e\u5dde\u662f\u4e00\u5bb6\u5168\u7403\u6027\u3001\u5546\u4e1a\u9636\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u7814\u7a76\u3001\u5f00\u53d1\u3001\u751f\u4ea7\u4ee5\u53ca\u5546\u4e1a\u5316\u521b\u65b0\u6027\u836f\u7269\u4ee5\u4e3a\u5168\u4e16\u754c\u60a3\u8005\u63d0\u9ad8\u7597\u6548\u548c\u836f\u54c1\u53ef\u53ca\u6027\u3002\u767e\u6d4e\u795e\u5dde\u76ee\u524d\u5728\u4e2d\u56fd\u5927\u9646\u3001\u7f8e\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u3001\u6b27\u6d32\u548c\u5176\u4ed6\u5730\u533a\u62e5\u67095200 \u591a\u540d\u5458\u5de5\uff0c\u6b63\u5728\u52a0\u901f\u63a8\u52a8\u516c\u53f8\u591a\u5143\u5316\u7684\u65b0\u578b\u764c\u75c7\u7597\u6cd5\u836f\u7269\u7ba1\u7ebf\u3002\u76ee\u524d\uff0c\u767e\u6d4e\u795e\u5dde\u4e24\u6b3e\u81ea\u4e3b\u7814\u53d1\u7684\u836f\u7269\uff0cBTK \u6291\u5236\u5242\u767e\u60a6\u6cfd®<\/sup>\uff08\u6cfd\u5e03\u66ff\u5c3c\u80f6\u56ca\uff09\u6b63\u5728\u7f8e\u56fd\u548c\u4e2d\u56fd\u8fdb\u884c\u9500\u552e\u3001\u6297PD-1 \u6297\u4f53\u836f\u7269\u767e\u6cfd\u5b89®<\/sup>\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\u6ce8\u5c04\u6db2\uff09\u5728\u4e2d\u56fd\u8fdb\u884c\u9500\u552e\u3002\u6b64\u5916\uff0c\u767e\u6d4e\u795e\u5dde\u5728\u4e2d\u56fd\u6b63\u5728\u6216\u8ba1\u5212\u9500\u552e\u591a\u6b3e\u7531\u5b89\u8fdb\u516c\u53f8\u3001\u65b0\u57fa\u7269\u6d41\u6709\u9650\u516c\u53f8\uff08\u96b6\u5c5e\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u516c\u53f8\uff09\u4ee5\u53caEUSA Pharma \u6388\u6743\u7684\u80bf\u7624\u836f\u7269\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95eewww.beigene.com.cn<\/a><\/u>\u3002<\/p>\n

\u767e\u6d4e\u795e\u5dde\u524d\u77bb\u6027\u58f0\u660e<\/b><\/p>\n

\u672c\u65b0\u95fb\u7a3f\u5305\u542b\u6839\u636e\u300a1995 \u5e74\u79c1\u4eba\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u300b\uff08Private Securities Litigation Reform Act of 1995\uff09\u4ee5\u53ca\u5176\u4ed6\u8054\u90a6\u8bc1\u5238\u6cd5\u5f8b\u4e2d\u5b9a\u4e49\u7684\u524d\u77bb\u6027\u58f0\u660e\uff0c\u5305\u62ec\u6709\u5173\u4e0eBITT\u8fbe\u6210\u7684\u72ec\u5bb6\u9009\u62e9\u548c\u6388\u6743\u534f\u8bae\u4e2d\u5bf9BITT\u7684\u5148\u8fdbTNFR2\u62ee\u6297\u5242\u6297\u4f53BITR2101\u548cBITT\u5176\u4ed6\u4e13\u5229\u4fdd\u62a4\u7684TNFR2\u62ee\u6297\u5242\u6297\u4f53\u7684\u8fdb\u4e00\u6b65\u5f00\u53d1\u3001\u53cc\u65b9\u5f00\u5c55\u4e0e\u767e\u6cfd\u5b89\u7ec4\u5408\u7528\u836f\u7814\u7a76\u7684\u8ba1\u5212\u3001TNFR2\u62ee\u6297\u5242\u6210\u4e3a\u6cbb\u7597\u764c\u75c7\u7684\u65b0\u578b\u6709\u6548\u9014\u5f84\u7684\u53ef\u80fd\u6027\u3001\u767e\u6d4e\u795e\u5dde\u83b7\u5f97\u72ec\u5bb6\u6388\u6743\u7684\u9009\u62e9\u6743\u548c\u9879\u76ee\u8bc1\u660e\u6982\u5ff5\u9a8c\u8bc1\u7684\u524d\u63d0\u6761\u4ef6\u3001\u53cc\u65b9\u7684\u627f\u8bfa\u3001\u5408\u4f5c\u6f5c\u5728\u7684\u5229\u76ca\u3001\u6f5c\u5728\u5411BITT\u652f\u4ed8\u7684\u6b3e\u9879\uff0c\u4ee5\u53ca\u5176\u4ed6\u975e\u5386\u53f2\u6027\u4fe1\u606f\u3002\u7531\u4e8e\u5404\u79cd\u91cd\u8981\u56e0\u7d20\u7684\u5f71\u54cd\uff0c\u5b9e\u9645\u7ed3\u679c\u53ef\u80fd\u4e0e\u524d\u77bb\u6027\u58f0\u660e\u6709\u91cd\u5927\u5dee\u5f02\u3002\u8fd9\u4e9b\u56e0\u7d20\u5305\u62ec\u4e86\u4ee5\u4e0b\u4e8b\u9879\u7684\u98ce\u9669\uff1a\u767e\u6d4e\u795e\u5dde\u8bc1\u660e\u5176\u5019\u9009\u836f\u7269\u529f\u6548\u548c\u5b89\u5168\u6027\u7684\u80fd\u529b\uff1b\u5019\u9009\u836f\u7269\u7684\u4e34\u5e8a\u7ed3\u679c\u53ef\u80fd\u4e0d\u652f\u6301\u8fdb\u4e00\u6b65\u5f00\u53d1\u6216\u4e0a\u5e02\u5ba1\u6279\uff1b\u836f\u653f\u90e8\u95e8\u7684\u884c\u52a8\u53ef\u80fd\u4f1a\u5f71\u54cd\u5230\u4e34\u5e8a\u8bd5\u9a8c\u7684\u542f\u52a8\u3001\u65f6\u95f4\u8868\u548c\u8fdb\u5c55\u4ee5\u53ca\u4ea7\u54c1\u4e0a\u5e02\u5ba1\u6279\uff1b\u767e\u6d4e\u795e\u5dde\u7684\u4e0a\u5e02\u4ea7\u54c1\u53ca\u5019\u9009\u836f\u7269\uff08\u5982\u80fd\u83b7\u6279\uff09\u83b7\u5f97\u5546\u4e1a\u6210\u529f\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u5bf9\u5176\u6280\u672f\u548c\u836f\u7269\u77e5\u8bc6\u4ea7\u6743\u4fdd\u62a4\u83b7\u5f97\u548c\u7ef4\u62a4\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u4f9d\u8d56\u7b2c\u4e09\u65b9\u8fdb\u884c\u836f\u7269\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5176\u4ed6\u670d\u52a1\u7684\u60c5\u51b5\uff1b\u767e\u6d4e\u795e\u5dde\u6709\u9650\u7684\u8425\u8fd0\u5386\u53f2\u548c\u83b7\u5f97\u8fdb\u4e00\u6b65\u7684\u8425\u8fd0\u8d44\u91d1\u4ee5\u5b8c\u6210\u5019\u9009\u836f\u7269\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u7684\u80fd\u529b\uff1b\u65b0\u51a0\u80ba\u708e\u5168\u7403\u5927\u6d41\u884c\u5bf9\u516c\u53f8\u4e34\u5e8a\u5f00\u53d1\u3001\u5546\u4e1a\u5316\u8fd0\u8425\u4ee5\u53ca\u5176\u4ed6\u4e1a\u52a1\u5e26\u6765\u7684\u5f71\u54cd\uff1b\u4ee5\u53ca\u767e\u6d4e\u795e\u5dde\u5728\u6700\u8fd1\u5b63\u5ea6\u62a5\u544a\u768410-Q \u8868\u683c\u4e2d\u201c\u98ce\u9669\u56e0\u7d20\u201d\u7ae0\u8282\u91cc\u66f4\u5168\u9762\u8ba8\u8bba\u7684\u5404\u7c7b\u98ce\u9669\uff1b\u4ee5\u53ca\u767e\u6d4e\u795e\u5dde\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u671f\u540e\u5448\u62a5\u4e2d\u5173\u4e8e\u6f5c\u5728\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u4ee5\u53ca\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u7684\u8ba8\u8bba\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u7684\u6240\u6709\u4fe1\u606f\u4ec5\u53ca\u4e8e\u65b0\u95fb\u7a3f\u53d1\u5e03\u4e4b\u65e5\uff0c\u9664\u975e\u6cd5\u5f8b\u8981\u6c42\uff0c\u767e\u6d4e\u795e\u5dde\u5e76\u65e0\u8d23\u4efb\u66f4\u65b0\u8be5\u7b49\u4fe1\u606f\u3002<\/p>\n

 <\/p>\n

\u76f8\u5173\u94fe\u63a5 :<\/p>\n

http:\/\/www.beigene.com<\/p>\n","protected":false},"excerpt":{"rendered":"

\u53cc\u65b9\u5728\u4e9a\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u8fbe\u6210\u72ec\u5bb6\u6388\u6743\uff0c\u5df2\u8ba1\u5212\u5f00\u5c55\u4e0e\u767e\u6d4e\u795e\u5dde\u6297PD-1\u6297\u4f53\u767e\u6cfd\u5b89\u00ae\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\uff09\u8054\u5408\u7684\u7814\u7a76 \u7f8e\u56fd\u9ebb\u7701\u6ce2\u58eb\u987f\u3001\u5251\u6865\u548c\u4e2d\u56fd\u5317\u4eac2021\u5e742\u670818\u65e5 \/\u7f8e\u901a\u793e\/ — Boston Immune Technologies and Therapeutics, Inc.\uff08\u4ee5\u4e0b\u7b80\u79f0\u201cBITT\u201d\uff09\u662f\u4e00\u5bb6\u5728\u764c\u75c7\u548c\u5176\u4ed6\u75be\u75c5\u9886\u57df\u4e13\u6ce8\u5f00\u53d1\u65b0\u578b\u62ee\u6297\u5242\u6297\u4f53\u7684\u79c1\u6709\u516c\u53f8\uff0c\u516c\u53f8\u4eca\u5929\u548c\u767e\u6d4e\u795e\u5dde\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aBGNE\uff1b\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a06160\uff09\u5ba3\u5e03\uff0c\u53cc\u65b9\u5df2\u8fbe\u6210\u4e00\u9879\u9009\u62e9\u548c\u6388\u6743\u534f\u8bae\uff0c\u76ee\u7684\u4e3a\u5f00\u53d1\u548c\u5546\u4e1a\u5316BITT\u521b\u65b0\u80bf\u7624\u574f\u6b7b\u56e0\u5b50\uff08TNF\uff09\u53d7\u4f532\u578b\uff08TNFR2\uff09\u62ee\u6297\u5242\u6297\u4f53\u3002\u767e\u6d4e\u795e\u5dde\u5df2\u7ecf\u83b7\u5f97BITT\u4e13\u5229\u4fdd\u62a4\u7684TNFR2\u62ee\u6297\u5242\u6297\u4f53\u5728\u591a\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u7684\u72ec\u5bb6\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u5316\u6388\u6743\u9009\u62e9\u6743\uff0c\u5305\u62ec\u4e9a\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u3002\u53cc\u65b9\u8ba1\u5212\u80fd\u542f\u52a8\u591a\u98791\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u7528\u4e8e\u8bc4\u4f30BITT\u7684\u5148\u8fdbTNFR2\u62ee\u6297\u5242\u6297\u4f53BITR2101\uff0c\u5305\u62ec\u5176\u8054\u5408\u767e\u6d4e\u795e\u5dde\u6297PD-1\u6297\u4f53\u767e\u6cfd\u5b89®\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\uff09\u7684\u7ec4\u5408\u7528\u836f\u7814\u7a76\u3002 BITT\u8054\u5408\u521b\u59cb\u4eba\u517c\u9996\u5e2d\u6267\u884c\u5b98Russell LaMontagne\u8868\u793a\uff1a\u201c\u4f5c\u4e3a\u4e00\u5bb6\u5168\u7403\u6027\u516c\u53f8\uff0c\u767e\u6d4e\u795e\u5dde\u5728\u652f\u6301\u751f\u7269\u79d1\u6280\u521b\u65b0\u65b9\u9762\u7ecf\u9a8c\u4e30\u5bcc\u3001\u58f0\u8a89\u5353\u8d8a\uff0c\u4e5f\u662f\u5e2e\u52a9\u5f00\u53d1\u6211\u4eec\u5148\u8fdb\u7684\u5728\u7814TNFR2\u6297\u4f53BITR2101\u7684\u7406\u60f3\u5408\u4f5c\u4f19\u4f34\u3002\u80fd\u4e0e\u767e\u6d4e\u795e\u5dde\u8fbe\u6210\u8be5\u9879\u5408\u4f5c\uff0c\u5728\u80af\u5b9aBITT\u6297\u4f53\u5f00\u53d1\u5e73\u53f0\u6280\u672f\u7684\u540c\u65f6\uff0c\u4e5f\u4e3aBITR2101\u8bc1\u660e\u5176\u6f5c\u529b\u63d0\u4f9b\u4e86\u4e00\u4e2a\u673a\u4f1a\uff0c\u65e0\u8bba\u662f\u4f5c\u4e3a\u5355\u836f\uff0c\u8fd8\u662f\u4e0e\u7c7b\u4f3c\u767e\u6cfd\u5b89®\u7684\u68c0\u67e5\u70b9\u6291\u5236\u5242\u8054\u5408\u3002\u201d TNFR2\u4e3aTNF\u53d7\u4f53\u8d85\u5bb6\u65cf\u6210\u5458\uff0c\u5728\u591a\u7c7b\u80bf\u7624\u4e2d\u7684\u9009\u62e9\u6027\u8868\u8fbe\u4e3a\u8868\u9762\u764c\u57fa\u56e0\uff0c\u5177\u6709\u4fc3\u8fdb\u80bf\u7624\u7ec6\u80de\u589e\u6b96\u7684\u529f\u80fd\u3002TNFR2\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\u4e5f\u4f1a\u8868\u8fbe\u5728\u6291\u5236\u6027\u514d\u75ab\u7ec6\u80de\u4e2d\uff0c\u5305\u62ec\u8c03\u8282\u6027T\u7ec6\u80de\uff08Tregs\uff09\u548c\u9ad3\u6e90\u6291\u5236\u6027\u7ec6\u80de\uff0c\u540c\u65f6\u4e5f\u662f\u514d\u75ab\u9003\u9038\u3001\u80bf\u7624\u751f\u957f\u4ee5\u53ca\u68c0\u67e5\u70b9\u963b\u65ad\u62b5\u6297\u6027\u7684\u6f5c\u5728\u9a71\u52a8\u529b\u3002 \u767e\u6d4e\u795e\u5dde\u9ad8\u7ea7\u526f\u603b\u88c1\u517c\u5916\u90e8\u521b\u65b0\u8d1f\u8d23\u4eba\u7f57\u4fa3\u677e\u535a\u58eb\u8bc4\u8bba\u9053\uff1a\u201cTNFR2\u662f\u4e00\u79cd\u5341\u5206\u6709\u610f\u601d\u7684\u9776\u70b9\uff0c\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\uff0c\u4f1a\u5728\u6291\u5236\u6027\u7ec6\u80de\u4e0a\u9ad8\u8868\u8fbe\u3002\u540c\u65f6\uff0c\u5b66\u754c\u4e5f\u6b63\u9010\u6e10\u8fbe\u6210\u5171\u8bc6\u2014\u2014TNFR2\u9776\u70b9\u4e5f\u8bb8\u4f1a\u6210\u4e3a\u6cbb\u7597\u764c\u75c7\u7684\u4e00\u6761\u65b0\u9896\u4e14\u6709\u6548\u7684\u9014\u5f84\u3002BITT\u5df2\u521b\u9020\u51fa\u9ad8\u5ea6\u80bf\u7624\u7279\u5b9a\u6027\u7684\u6297\u4f53\uff0c\u5177\u6709\u72ec\u7279\u3001\u65b0\u9896\u7684\u7ed3\u5408\u5f62\u6001\u3002\u6211\u4eec\u671f\u5f85\u4e0eBITT\u5408\u4f5c\uff0c\u770b\u5230BITR2101\u4f5c\u4e3a\u5355\u836f\u4ee5\u53ca\u4e0e\u767e\u6cfd\u5b89®\u8054\u5408\u7684\u4e34\u5e8a\u6570\u636e\u3002\u201d \u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0cBITT\u5c06\u83b7\u5f97\u5171\u8ba11660\u4e07\u7f8e\u5143\u7684\u9884\u4ed8\u6b3e\u4ee5\u53ca\u8fd1\u671f\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff0c\u5176\u4e2d\u5305\u62ec\u767e\u6d4e\u795e\u5dde\u5728\u6982\u5ff5\u9a8c\u8bc1\u7814\u7a76\u540e\u884c\u4f7f\u9009\u62e9\u6743\u3002\u6b64\u5916\uff0c\u5728\u767e\u6d4e\u795e\u5dde\u884c\u4f7f\u9009\u62e9\u6743\u540e\uff0cBITT\u6709\u8d44\u683c\u83b7\u5f97\u81f3\u591a\u4e3a1.05\u4ebf\u7f8e\u5143\u7684\u5f00\u53d1\u3001\u6ce8\u518c\u53ca\u9500\u552e\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff0c\u53e6\u52a0\u5728\u6388\u6743\u5730\u533a\u7684\u5206\u7ea7\u4ea7\u54c1\u9500\u552e\u7279\u8bb8\u4f7f\u7528\u8d39\u3002\u8fde\u540c\u8be5\u9879\u72ec\u5bb6\u9009\u62e9\u548c\u6388\u6743\u534f\u8bae\uff0c\u767e\u6d4e\u795e\u5dde\u540c\u65f6\u53c2\u4e0e\u4e86BITT\u7684A\u8f6e\u4f18\u5148\u80a1\u878d\u8d44\uff0c\u4e3a\u5176\u6295\u8d44400\u4e07\u7f8e\u5143\u3002 \u5173\u4e8eBoston Immune Technologies and Therapeutics Boston Immune Technologies and Therapeutics\uff08BITT\uff09\u662f\u4e00\u5bb6\u4f4d\u4e8e\u7f8e\u56fd\u6ce2\u58eb\u987f\u7684\u516c\u53f8\uff0c\u5728\u80bf\u7624\u3001\u708e\u75c7\u3001\u81ea\u8eab\u514d\u75ab\u6027\u548c\u611f\u67d3\u6027\u75be\u75c5\u9886\u57df\u4e2d\uff0c\u4e13\u6ce8\u5f00\u53d1TNF\u8d85\u5bb6\u65cf\u53d7\u4f53\u7684\u65b0\u578b\u62ee\u6297\u5242\u6297\u4f53\u3002BITR2101\u4e3a\u516c\u53f8\u6700\u4e3a\u5148\u8fdb\u7684\u5019\u9009\u836f\u7269\uff0c\u662f\u4e00\u6b3e\u4ee5\u80bf\u7624\u574f\u6b7b\u56e0\u5b50\u53d7\u4f532\u578b\uff08TNFR2\uff09\u4e3a\u9776\u70b9\u7684\u5355\u514b\u9686\u6297\u4f53\uff0cBITT\u6b63\u5728\u8ba1\u5212\u542f\u52a8BITR2101\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002\u540c\u65f6\uff0cBITT\u6b63\u5728\u5f00\u53d1\u5176\u4ed6\u591a\u9879TNF\u8d85\u5bb6\u65cf\u6297\u4f53\uff0c\u5305\u62ec\u5728\u9a8c\u8bc1\u4e2d\u5f00\u53d1CD40\u62ee\u6297\u5242\u3001\u5728\u80bf\u7624\u5b66\u4e2d\u5f00\u53d1CD30\u62ee\u6297\u5242\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u516c\u53f8\u5b98\u7f51www.bostonimmunetech.com\u3002 \u5173\u4e8e\u767e\u6d4e\u795e\u5dde \u767e\u6d4e\u795e\u5dde\u662f\u4e00\u5bb6\u5168\u7403\u6027\u3001\u5546\u4e1a\u9636\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u7814\u7a76\u3001\u5f00\u53d1\u3001\u751f\u4ea7\u4ee5\u53ca\u5546\u4e1a\u5316\u521b\u65b0\u6027\u836f\u7269\u4ee5\u4e3a\u5168\u4e16\u754c\u60a3\u8005\u63d0\u9ad8\u7597\u6548\u548c\u836f\u54c1\u53ef\u53ca\u6027\u3002\u767e\u6d4e\u795e\u5dde\u76ee\u524d\u5728\u4e2d\u56fd\u5927\u9646\u3001\u7f8e\u56fd\u3001\u6fb3\u5927\u5229\u4e9a\u3001\u6b27\u6d32\u548c\u5176\u4ed6\u5730\u533a\u62e5\u67095200 \u591a\u540d\u5458\u5de5\uff0c\u6b63\u5728\u52a0\u901f\u63a8\u52a8\u516c\u53f8\u591a\u5143\u5316\u7684\u65b0\u578b\u764c\u75c7\u7597\u6cd5\u836f\u7269\u7ba1\u7ebf\u3002\u76ee\u524d\uff0c\u767e\u6d4e\u795e\u5dde\u4e24\u6b3e\u81ea\u4e3b\u7814\u53d1\u7684\u836f\u7269\uff0cBTK \u6291\u5236\u5242\u767e\u60a6\u6cfd®\uff08\u6cfd\u5e03\u66ff\u5c3c\u80f6\u56ca\uff09\u6b63\u5728\u7f8e\u56fd\u548c\u4e2d\u56fd\u8fdb\u884c\u9500\u552e\u3001\u6297PD-1 \u6297\u4f53\u836f\u7269\u767e\u6cfd\u5b89®\uff08\u66ff\u96f7\u5229\u73e0\u5355\u6297\u6ce8\u5c04\u6db2\uff09\u5728\u4e2d\u56fd\u8fdb\u884c\u9500\u552e\u3002\u6b64\u5916\uff0c\u767e\u6d4e\u795e\u5dde\u5728\u4e2d\u56fd\u6b63\u5728\u6216\u8ba1\u5212\u9500\u552e\u591a\u6b3e\u7531\u5b89\u8fdb\u516c\u53f8\u3001\u65b0\u57fa\u7269\u6d41\u6709\u9650\u516c\u53f8\uff08\u96b6\u5c5e\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u516c\u53f8\uff09\u4ee5\u53caEUSA Pharma \u6388\u6743\u7684\u80bf\u7624\u836f\u7269\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95eewww.beigene.com.cn\u3002 \u767e\u6d4e\u795e\u5dde\u524d\u77bb\u6027\u58f0\u660e \u672c\u65b0\u95fb\u7a3f\u5305\u542b\u6839\u636e\u300a1995 \u5e74\u79c1\u4eba\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u300b\uff08Private Securities Litigation Reform Act of 1995\uff09\u4ee5\u53ca\u5176\u4ed6\u8054\u90a6\u8bc1\u5238\u6cd5\u5f8b\u4e2d\u5b9a\u4e49\u7684\u524d\u77bb\u6027\u58f0\u660e\uff0c\u5305\u62ec\u6709\u5173\u4e0eBITT\u8fbe\u6210\u7684\u72ec\u5bb6\u9009\u62e9\u548c\u6388\u6743\u534f\u8bae\u4e2d\u5bf9BITT\u7684\u5148\u8fdbTNFR2\u62ee\u6297\u5242\u6297\u4f53BITR2101\u548cBITT\u5176\u4ed6\u4e13\u5229\u4fdd\u62a4\u7684TNFR2\u62ee\u6297\u5242\u6297\u4f53\u7684\u8fdb\u4e00\u6b65\u5f00\u53d1\u3001\u53cc\u65b9\u5f00\u5c55\u4e0e\u767e\u6cfd\u5b89\u7ec4\u5408\u7528\u836f\u7814\u7a76\u7684\u8ba1\u5212\u3001TNFR2\u62ee\u6297\u5242\u6210\u4e3a\u6cbb\u7597\u764c\u75c7\u7684\u65b0\u578b\u6709\u6548\u9014\u5f84\u7684\u53ef\u80fd\u6027\u3001\u767e\u6d4e\u795e\u5dde\u83b7\u5f97\u72ec\u5bb6\u6388\u6743\u7684\u9009\u62e9\u6743\u548c\u9879\u76ee\u8bc1\u660e\u6982\u5ff5\u9a8c\u8bc1\u7684\u524d\u63d0\u6761\u4ef6\u3001\u53cc\u65b9\u7684\u627f\u8bfa\u3001\u5408\u4f5c\u6f5c\u5728\u7684\u5229\u76ca\u3001\u6f5c\u5728\u5411BITT\u652f\u4ed8\u7684\u6b3e\u9879\uff0c\u4ee5\u53ca\u5176\u4ed6\u975e\u5386\u53f2\u6027\u4fe1\u606f\u3002\u7531\u4e8e\u5404\u79cd\u91cd\u8981\u56e0\u7d20\u7684\u5f71\u54cd\uff0c\u5b9e\u9645\u7ed3\u679c\u53ef\u80fd\u4e0e\u524d\u77bb\u6027\u58f0\u660e\u6709\u91cd\u5927\u5dee\u5f02\u3002\u8fd9\u4e9b\u56e0\u7d20\u5305\u62ec\u4e86\u4ee5\u4e0b\u4e8b\u9879\u7684\u98ce\u9669\uff1a\u767e\u6d4e\u795e\u5dde\u8bc1\u660e\u5176\u5019\u9009\u836f\u7269\u529f\u6548\u548c\u5b89\u5168\u6027\u7684\u80fd\u529b\uff1b\u5019\u9009\u836f\u7269\u7684\u4e34\u5e8a\u7ed3\u679c\u53ef\u80fd\u4e0d\u652f\u6301\u8fdb\u4e00\u6b65\u5f00\u53d1\u6216\u4e0a\u5e02\u5ba1\u6279\uff1b\u836f\u653f\u90e8\u95e8\u7684\u884c\u52a8\u53ef\u80fd\u4f1a\u5f71\u54cd\u5230\u4e34\u5e8a\u8bd5\u9a8c\u7684\u542f\u52a8\u3001\u65f6\u95f4\u8868\u548c\u8fdb\u5c55\u4ee5\u53ca\u4ea7\u54c1\u4e0a\u5e02\u5ba1\u6279\uff1b\u767e\u6d4e\u795e\u5dde\u7684\u4e0a\u5e02\u4ea7\u54c1\u53ca\u5019\u9009\u836f\u7269\uff08\u5982\u80fd\u83b7\u6279\uff09\u83b7\u5f97\u5546\u4e1a\u6210\u529f\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u5bf9\u5176\u6280\u672f\u548c\u836f\u7269\u77e5\u8bc6\u4ea7\u6743\u4fdd\u62a4\u83b7\u5f97\u548c\u7ef4\u62a4\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u4f9d\u8d56\u7b2c\u4e09\u65b9\u8fdb\u884c\u836f\u7269\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5176\u4ed6\u670d\u52a1\u7684\u60c5\u51b5\uff1b\u767e\u6d4e\u795e\u5dde\u6709\u9650\u7684\u8425\u8fd0\u5386\u53f2\u548c\u83b7\u5f97\u8fdb\u4e00\u6b65\u7684\u8425\u8fd0\u8d44\u91d1\u4ee5\u5b8c\u6210\u5019\u9009\u836f\u7269\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u7684\u80fd\u529b\uff1b\u65b0\u51a0\u80ba\u708e\u5168\u7403\u5927\u6d41\u884c\u5bf9\u516c\u53f8\u4e34\u5e8a\u5f00\u53d1\u3001\u5546\u4e1a\u5316\u8fd0\u8425\u4ee5\u53ca\u5176\u4ed6\u4e1a\u52a1\u5e26\u6765\u7684\u5f71\u54cd\uff1b\u4ee5\u53ca\u767e\u6d4e\u795e\u5dde\u5728\u6700\u8fd1\u5b63\u5ea6\u62a5\u544a\u768410-Q \u8868\u683c\u4e2d\u201c\u98ce\u9669\u56e0\u7d20\u201d\u7ae0\u8282\u91cc\u66f4\u5168\u9762\u8ba8\u8bba\u7684\u5404\u7c7b\u98ce\u9669\uff1b\u4ee5\u53ca\u767e\u6d4e\u795e\u5dde\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u671f\u540e\u5448\u62a5\u4e2d\u5173\u4e8e\u6f5c\u5728\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u4ee5\u53ca\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u7684\u8ba8\u8bba\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u7684\u6240\u6709\u4fe1\u606f\u4ec5\u53ca\u4e8e\u65b0\u95fb\u7a3f\u53d1\u5e03\u4e4b\u65e5\uff0c\u9664\u975e\u6cd5\u5f8b\u8981\u6c42\uff0c\u767e\u6d4e\u795e\u5dde\u5e76\u65e0\u8d23\u4efb\u66f4\u65b0\u8be5\u7b49\u4fe1\u606f\u3002   \u76f8\u5173\u94fe\u63a5 : http:\/\/www.beigene.com… Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-20616","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/20616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=20616"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/20616\/revisions"}],"predecessor-version":[{"id":20617,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/20616\/revisions\/20617"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=20616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=20616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=20616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}